Q1 2025
Released May 8, 2025, after the close
10-Q filed May 15, 2025, 45 days after period end · 0001641172-25-010836
Q1 2025 · 10-Q
Revenue$4.88M$4.88M +38.5% vs Q1 2024+26.0% vs Q4 2024
Net Income$558.00K$558.00K N/M vs Q1 2024+59.9% vs Q4 2024
EPS Diluted$0.05$0.05 N/M vs Q1 2024no prior Q4 2024 on file
Gross Profit$3,154,000+44.2%
Operating Income$566,000N/M
Operating Cash Flow$322,000N/M
Margins · derived
Gross margin64.7%+2.6 pt vs Q1 2024
Operating margin11.6%+17.3 pt vs Q1 2024
Net margin11.4%+16.2 pt vs Q1 2024
What the release said
The release
Same quarter
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $4.88M | $3.52M | $3.70M | $2.16M |
| Net Income | $558.00K | -$169.00K | -$306.00K | -$1.97M |
| EPS Diluted | $0.05 | -$0.02 | -$0.03 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR